Bridgebio Pharma Inc (BBIO)

Operating Cash Flow (Statement)

-$71.10M

Quarterly · Period ending: · USD

BBIO logo

BBIO Operating Cash Flow (Statement)

Latest reported-$71.10M
BBIO Quarterly Cash from Operations (-$17.95M → -$71.10M)
High-resolution chart · PNG

BBIO operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-71,101,000
-197,279,000
-56,420,000
-109,574,000
-80,681,000
-199,235,000
-195,326,000
-180,566,000
74,703,000
-219,537,000
-124,819,000
-145,226,000
-113,353,000
-144,322,000
-93,243,000
-135,163,000
-30,453,000
-160,635,000
-133,895,000
-121,561,000
-91,713,000
-150,765,000
-96,261,000
-131,684,000
-87,849,000
-83,920,000
-76,203,000
-49,996,000
-68,248,000
-59,140,000
-46,414,000
-38,322,000
-33,956,000
-17,951,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.